Tharimmune
Price & Volume
Stats
See more52W Range | $0.95-$9.08 |
Market Cap | $187.3M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.68 |
News
See moreYahoo Finance • last month
Catherine Wood's Strategic Moves: A Closer Look at Tesla Inc's Portfolio Impact
Yahoo Finance • 7 months ago
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
Yahoo Finance • 7 months ago
Tharimmune (THUR) Tumbles 20.7% on $5-Million Share Sale
Yahoo Finance • 7 months ago
Unusual volume stocks in Thursday's session
About
CEO | Mr. Mark Wendland |
Address | 34 Shrewsbury Avenue, Red Bank, NJ, United States, 07701 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |
